Yikestar Pharma
益科思特
Yikestar Pharma
Biotech/Healthcare
Excellmab (Beijing) Pharmaceutical Technology Development Co., Ltd. develops and commercializes monoclonal antibody therapies, multifunctional antibody therapies, and CAR-T/TCR-T cell immunotherapies.
Latest round: Strategic (2026)
Source: ChinaBulls — chinabulls.com
Last updated 2026-02-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.